Not available
Quote | Danaher Corporation (NYSE:DHR)
Last: | $273.91 |
---|---|
Change Percent: | -0.67% |
Open: | $271.9 |
Close: | $273.91 |
High: | $277.72 |
Low: | $271.19 |
Volume: | 2,802,556 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Danaher Corporation (NYSE:DHR)
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
Message Board Posts | Danaher Corporation (NYSE:DHR)
Subject | By | Source | When |
---|---|---|---|
$DHR oh yeah news for the day | Sam Dan | investorshub | 06/19/2023 10:18:10 AM |
The now last up | Sam Dan | investorshub | 06/18/2023 11:57:53 PM |
$DHR Have a look at this | Sam Dan | investorshub | 06/16/2023 4:25:23 PM |
$DHR Price trading | Sam Dan | investorshub | 06/15/2023 5:42:03 PM |
$DHR The gaining | Sam Dan | investorshub | 06/15/2023 5:55:10 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...